With the release of the latest guidelines on what is and isn’t a psychiatric disorder (DSM-5) the debate is once again raging over whether psychiatry has gone too far. Claims of mis-prescribing, over-medicalisation and catch-all diagnoses that could see most of us labelled as having a mental health disorder have come on top of statements that psychiatrists are too closely tied to drug companies and are focussing too much on biological causes that have little impact on recognising or treating disorders.
On the eve of DSM-5 publication the SMC gathered some of the top UK experts from psychology, psychiatry and beyond to preview DSM-5 and discuss everything from drugs to classification to environmental causes and the evidence behind therapies.
Prof Elizabeth Kuipers, Professor of Clinical Psychology, Head of Department of Psychology, King’s College London’s Institute of Psychiatry
Prof David Clark, Professor of Experimental Psychology, University of Oxford and Honorary Fellow of the British Psychological Society
Prof Nick Craddock, Professor of Psychiatry, University of Cardiff and Director of the National Centre for Mental Health, Wales
Prof David Taylor, Royal Pharmaceutical Society expert and spokesperson on mental health medicines and Editor of the Maudsley Prescribing Guidelines
Andy Bell, Deputy Chief Executive, The Centre for Mental Health